Navigation Links
Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Date:11/10/2008

Phase 2 clinical development for multiple tumor types. The Company also has an in-licensing and acquisition program designed to identify and acquire additional drug candidates. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future clinical and business prospects for KRX-0401, may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully complete clinical trials for KRX-0401; our ability to meet anticipated development timelines for KRX-0401 due to recruitment, clinical trial results, manufacturing capabilities or other factors; and other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information in our website and in the American Society of Hematology's website is not incorporated by reference into this press release and is included as an inactive textual reference only.

KERYX CONTACT:

Lauren Fischer

Director - Investor Relations

Keryx Biopharmaceuticals, Inc.

Tel: 212.531.5965

E-mail: lfischer@keryx.com


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
2. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
6. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
7. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
8. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
9. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
10. Lippincott Williams & Wilkins Selected as Publisher of the Journal of Neuroscience Nursing
11. Emdeon Selected by the Maryland Hospital Association to Power the Maryland Transaction Data Interchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... September 30, 2014 Foundations Recovery Network, ... announce the start of its 40th national conference by ... as a featured keynote speaker at the Moments of ... specializing in the fields of addiction and mental health ... Beach, Fla., September 29 – October 2, 2014, at ...
(Date:9/29/2014)... September 30, 2014 Atlantic NeuroSurgical Specialists ... their annual picnic to celebrate their strides in their fight ... at 6:00 p.m. at their Morristown office. , The annual ... 2012 and is a place where patients can find love, ... the picnic food and activities were enjoyed by guests, including ...
(Date:9/29/2014)... Garden City, NY (PRWEB) September 30, 2014 ... M.D., as a 2014 Professional Woman of the ... for leadership in gynecology and preventative medicine As the ... country, spanning virtually every industry and profession, the National ... community with over 600,000 members and nearly 300 Local ...
(Date:9/29/2014)... 29, 2014 Park Avenue Dental, a ... Dr. Michael A. Sherman who has dedicated his career ... care, has announced its inclusion in the Patient Connect ... patients access to private accounts so that they may ... Further, the system also allows patients to request appointments, ...
(Date:9/29/2014)... 2014 (PRWEB) September 29, 2014 Globally ... tablets and laptops provides the delivery of training, anyplace, ... youth to adult, to raise and enhance one’s job ... or to obtain certification in your chosen field. , ... to compete effectively and at MMU we make it ...
Breaking Medicine News(10 mins):Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 2Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 3Health News:Local Brain Tumor Foundation, ANS Center of Hope, Celebrates its Brain Cancer Patients 2Health News:National Association of Professional Women Announces Victoria J. Mondloch, M.D., Family Medicine and Women's Health, a 2014 Professional Woman of the Year 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 3Health News:MyMobileUniversity invites Corporations, Government Public Agencies, Academia, NGOs’ to Transform Workforce Development by Continued Education, Learning to Impact Lives 2Health News:MyMobileUniversity invites Corporations, Government Public Agencies, Academia, NGOs’ to Transform Workforce Development by Continued Education, Learning to Impact Lives 3
... ... ... ... ...
... ... dietary supplements, including two popular weight loss supplements, according to new tests by ... weight loss products and ConsumerLab.com noted concern for potential side-effects from products containing ... 7-keto DHEA supplements. , ...
... , ... blasts away the pounds in a fitness competition to claim coveted tech prizes. , ... Salt Lake City, UT (Vocus) March 3, 2010 ... shape up – just a few, sweet tech prizes., , , , ,"Mention ,iPad, or ,Dell ...
... ... 25 recipient list for the 2010 Diversity Council Honors Award™. The recipients’ rankings ... 2010 Linkage Summit on Leading Diversity Conference, April 27 in Atlanta. , ... (PRWEB) March 4, 2010 -- The ...
... ... ... -- Brown Dog Foundation , a Nashville-based nonprofit dedicated to helping pets in need ... Cat Competition. In this 10-week fundraising campaign, dogs and cats vie for the coveted title ...
... ... ... ... ...
Cached Medicine News:Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 2Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 3Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 4Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 5Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 6Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 7Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 8Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 2Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 3Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 4Health News:SEO.com Slims Down in Company Fitness Contest 2Health News:The Association of Diversity Councils Announces Its 2010 Diversity Council Honors Award™ Recipients 2Health News:The Association of Diversity Councils Announces Its 2010 Diversity Council Honors Award™ Recipients 3Health News:ATTENTION: Pawty Animals Needed in Nashville, Tennessee 2Health News:ATTENTION: Pawty Animals Needed in Nashville, Tennessee 3Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 2Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 3Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 4Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 5
(Date:9/29/2014)... Sept. 29, 2014 EU5 Sigmoidoscopes Market ... report, "EU5 Sigmoidoscopes Market Outlook to 2020", provides ... The report provides value, in millions of US ... US dollars) within market segments - Flexible Video ... Flexible Non-Video (Fibre) Sigmoidoscopes). The report ...
(Date:9/29/2014)... 2014  Following US and European approvals of Elekta,s ... and Drug Administration (CFDA) has cleared the radiation therapy ... According to the International Agency for Research on ... cancer every year in China ... colorectal, liver and esophageal cancers 2 . Versa HD ...
(Date:9/29/2014)... , Sept. 29, 2014  Guerbet, a ... medical imaging, has received a Drug Shortage Assistance ... for its assistance in preventing or alleviating a ... for its efforts related to the shortage of ... drug application, submitting several post-approval supplements to restart ...
Breaking Medicine Technology:EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3Guerbet Receives FDA's Drug Shortage Assistance Award: Recognized for contributions to address a shortage of Ethiodol (ethiodized oil) injection 2
... SUNNYVALE, California, September 23, 2010, ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Reata Pharmaceuticals Announce Agreement to Develop and... -- ABBOTT PARK, Ill. and IRVING, Texas, Sept. 23 ... ... (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
Cached Medicine Technology:Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 2Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 3Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 4Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 5Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 6Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 7Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 8Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 9Health Language and HCL Technologies Partner to Offer ICD-10 Conversion Solution 10Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 2Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 3Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 4Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 5Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 6Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 7Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 8Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 9
The PC3200h has three shelves and will hold three PF96h agitators. Total capacity is 288 random bags (96 apheresis bags)....
The PC4200i is the largest capacity platelet incubator available. It features a built-in agitator with a capacity of 396 random bags (132 apheresis)....
The PC2200i contains two shelves and will hold two PF96i agitators. It can store 192 random bags (64 apheresis bags)....
... rotators and agitators for continual ... set at 22C (71F) or ... (59F to 104F). Uniformity is ... bottom. Recorder is standard on ...
Medicine Products: